Moderate riskFDA DrugClass II

Major Pharmaceuticals Levothyroxine Sodium Tablets recalled for subpotency

Major Pharmaceuticals issued a recall of Levothyroxine Sodium Tablets, USP, 88 mcg (Lot #N02310, expiration 01/2027) because the tablets may contain less active ingredient than labeled. This means patients taking this medication may not receive the full intended dose of thyroid hormone.

From the FDA notice · Read the official notice ↗

What to do

  1. If you take this medication, contact your pharmacy or doctor to confirm whether you have the recalled lot.
  2. Do not stop taking your levothyroxine without talking to your doctor—stopping suddenly can cause serious health problems.
  3. Your pharmacy can provide a replacement from a different lot or manufacturer.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6952-61
Sold in
Nationwide

This recall covers 12 products — see all of them.

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Classification
Class II
Recall number
D-0703-2026

In the FDA's words

Description
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6952-61 Subpotent Drug Lot #: N02310, Exp. Date 01/2027 Distribution: Nationwide in the USA. Affected quantity: N/A
Hazard
Subpotent Drug

12 products in this recall

The agency lists each product separately. Check every one you might have.

Related topics